Search results
Results from the WOW.Com Content Network
Was the Department of Health Division of Medical Marijuana and Integrative Therapy until October 1, 2020; [6] medical cannabis only – there is no regulatory agency for other use. [a] Puerto Rico Medical Cannabis Regulatory Board (a division of the Puerto Rico Department of Health). The Board was created in 2017 under the MEDICINAL Act of 2017 ...
An application for a medical cannabis registry card includes a $25 fee and the patient’s written certification. On top of that, patients will need to include a notarized signature page.
A medical cannabis card in California. A medical cannabis card or medical marijuana card is a state-issued identification card that enables a patient with a doctor's recommendation to obtain, possess, or cultivate cannabis for medicinal use despite marijuana's lack of the normal Food and Drug Administration testing for safety and efficacy.
In the United States, cannabis is legal in 39 of 50 states for medical use and 24 states for recreational use. At the federal level, cannabis is classified as a Schedule I drug under the Controlled Substances Act, determined to have a high potential for abuse and no accepted medical use, prohibiting its use for any purpose. [1]
The state Division of Cannabis Control began accepting applications Friday for new dual licenses that will allow existing medical marijuana dispensaries to also sell nonmedical cannabis.
The Department of Cannabis Control (formerly the Bureau of Cannabis Control, originally established as Bureau of Marijuana Control under Proposition 64, [1] [2] formerly the Bureau of Medical Marijuana Regulation [3] [4]) is an agency of the State of California within the Department of Consumer Affairs, charged with regulating medical cannabis (MMJ) in accordance with state law pursuant to the ...
Nevada regulators have issued the first license to operate a lounge where cannabis can be consumed recreationally, marking the first of what are expected to be dozens of such operations. The state ...
Cannabis was commonly sold in tincture form by Parke-Davis, Eli Lilly, E. R. Squibb & Sons, and other drug manufacturers. [10] [11] By the end of the 19th century, the use of cannabis in medicine had declined due to a number of factors, including difficulty in controlling dosages and the rise in popularity of synthetic and opium-derived drugs. [9]